Literature DB >> 15371825

Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping.

Bernard H Bochner1, Daniel Cho, Harry W Herr, Machele Donat, Michael W Kattan, Guido Dalbagni.   

Abstract

PURPOSE: Accumulating evidence supports the relationship between an increased number of lymph nodes (LNs) reported following radical cystectomy (RC) and overall outcome. We prospectively evaluated RC cases with transitional cell carcinoma of the bladder to determine which factors may contribute to the variability in the number of reported LNs.
MATERIALS AND METHODS: We conducted a prospective evaluation in which 144 patients undergoing RC and pelvic lymph node dissection (PLND) between June 2001 and April 2003 were included. Lymph nodes were processed as individual packets. A standard method of evaluating nodal submissions was used. A mixed statistical model was used with neoadjuvant chemotherapy, node status, pathological stage, bacillus Calmette-Guerin exposure, age and number of days from transurethral resection as the fixed effects. Surgeon and pathologist were treated as random effects.
RESULTS: The extended PLND group had a significantly greater lymph node yield (median 22.5 nodes) compared to standard PLND (median 8), however, no staging advantage was observed in the extended dissection group. Only the type of PLND performed was associated with node yield (p <0.001). Subset analysis of patients with unexpected microscopic nodal involvement revealed that 33% had involvement of the common iliac nodes.
CONCLUSIONS: In our series only the extent of the lymph node dissection was found to influence node yield significantly after radical cystectomy. Additionally, the observed risk of involvement of the common iliac chain in microscopically node positive cases suggests a need to include this region as part of the PLND for bladder cancer for cases without grossly involved LNs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15371825     DOI: 10.1097/01.ju.0000137817.56888.d1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  38 in total

1.  Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder.

Authors:  Douglas A Mata; Susan Groshen; Friedrich-Carl Von Rundstedt; Donald G Skinner; Walter M Stadler; Richard J Cote; John P Stein; Seth P Lerner
Journal:  J Surg Oncol       Date:  2015-04-14       Impact factor: 3.454

2.  The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer.

Authors:  Brett S Carver; Angel M Cronin; Scott Eggener; Caroline J Savage; Robert J Motzer; Dean Bajorin; George J Bosl; Joel Sheinfeld
Journal:  Urology       Date:  2010-03-17       Impact factor: 2.649

Review 3.  The role and extent of pelvic lymphadenectomy in the management of patients with invasive urothelial carcinoma.

Authors:  Seth P Lerner
Journal:  Curr Treat Options Oncol       Date:  2009-06-30

4.  Prognostic impact of comorbidity in patients with bladder cancer.

Authors:  Ifeanyichukwu I Megwalu; Anna Vlahiotis; Mohamed Radwan; Jay F Piccirillo; Adam S Kibel
Journal:  Eur Urol       Date:  2007-11-05       Impact factor: 20.096

5.  Role of lymphadenectomy for invasive bladder cancer.

Authors:  Faysal A Yafi; Wassim Kassouf
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

6.  Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference?

Authors:  Magnus Holmer; Pär-Ola Bendahl; Thomas Davidsson; Sigurdur Gudjonsson; Wiking Månsson; Fredrik Liedberg
Journal:  World J Urol       Date:  2009-01-15       Impact factor: 4.226

7.  Oncologic outcomes between open and robotic-assisted radical cystectomy: a propensity score matched analysis.

Authors:  Michael Ahdoot; Leanne Almario; Hiwot Araya; Jonas Busch; Simon Conti; Mark L Gonzalgo
Journal:  World J Urol       Date:  2014-01-28       Impact factor: 4.226

8.  Identification of lymphatic pathway involved in the spread of bladder cancer: Evidence obtained from fluorescence navigation with intraoperatively injected indocyanine green.

Authors:  Shogo Inoue; Hiroaki Shiina; Yozo Mitsui; Hiroaki Yasumoto; Akio Matsubara; Mikio Igawa
Journal:  Can Urol Assoc J       Date:  2013-05-13       Impact factor: 1.862

9.  Role of pelvic lymphadenectomy in the treatment of bladder cancer: a mini review.

Authors:  Ja Hyeon Ku
Journal:  Korean J Urol       Date:  2010-06-21

10.  Lymphadenectomy in bladder cancer: What should be the extent?

Authors:  K Muruganandham; A Mandhani
Journal:  Indian J Urol       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.